Document Detail


Interleukin-6 protects human macrophages from cellular cholesterol accumulation and attenuates the pro-inflammatory response.
MedLine Citation:
PMID:  21757719     Owner:  NLM     Status:  Publisher    
Abstract/OtherAbstract:
Cholesterol-laden monocyte-derived macrophages are phagocytic cells characteristic of early and advanced atherosclerotic lesions. Interleukin-6 (IL-6) is a macrophage secretory product which is abundantly expressed in atherosclerotic plaques but whose precise role in atherogenesis is unclear. The capacity of macrophages to clear apoptotic cells, through the efferocytosis mechanism, as well as to reduce cellular cholesterol accumulation contributes to prevent plaque progression and instability. By virtue of its capacity to promote cellular cholesterol efflux from phagocyte-macrophages, ABCA1 was reported to reduce atherosclerosis. We demonstrated that lipid loading in human macrophages was accompanied by a strong increase of IL-6 secretion. Interestingly, IL-6 markedly induced ABCA1 expression and enhanced ABCA1-mediated cholesterol efflux from human macrophages to apoAI. Stimulation of ABCA1-mediated cholesterol efflux by IL-6 was however abolished by selective inhibition of the Jak-2/Stat3 signalling pathway. In addition, IL-6 enhanced the capacity of human macrophages to phagocytose apoptotic cells and stimulates the ABCA1-mediated efflux of cholesterol derived from the ingestion of free cholesterol-loaded apoptotic macrophages. Finally, the treatment of human macrophages with IL-6 led to the establishment of an anti-inflammatory cytokine profile, characterized by an increased secretion of IL-4 and IL-10, together with a decrease of that of IL-1b. Taken together, our results suggest that high amounts of IL-6 secreted by lipid laden human macrophages may constitute a protective response from macrophages to prevent accumulation of cytotoxic free cholesterol. Such a cellular recycling of free cholesterol may contribute to reduce both foam cell formation and the accumulation of apoptotic bodies as well as intraplaque inflammation in atherosclerotic lesions.
Authors:
Eric Frisdal; Philippe Lesnik; Maryline Olivier; Paul Robillard; M John Chapman; Thierry Huby; Maryse Guerin; Wilfried Le Goff
Related Documents :
20532209 - Epithelial p38alpha controls immune cell recruitment in the colonic mucosa.
17184869 - Mucosal immunomodulation by the non-bacterial fraction of milk fermented by lactobacill...
16023789 - Intestinal involvement is not sufficient to explain hypertransaminasemia in celiac dise...
21334249 - Regulation of hepatocyte fate by interferon-γ.
20203509 - Mast cells and mastocytosis.
11044159 - Interleukin 10-deficient colitis: new similarities to human inflammatory bowel disease.
16953829 - Apoptosis in liver disease.
19842039 - Mouse 3t3-l1 cells acquire resistance against oxidative stress as the adipocytes differ...
15573129 - Mechanisms and functional significance of tumour-induced dendritic-cell defects.
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2011-7-8
Journal Detail:
Title:  The Journal of biological chemistry     Volume:  -     ISSN:  1083-351X     ISO Abbreviation:  -     Publication Date:  2011 Jul 
Date Detail:
Created Date:  2011-7-15     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  2985121R     Medline TA:  J Biol Chem     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Affiliation:
INSERM UMR S939, France.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Histidine-rich glycoprotein binds fibrin(ogen) with high affinity and competes with thrombin for bin...
Next Document:  The SKP1-Cul1-F-box and leucine-rich repeat protein 4 (SCF-FbxL4) ubiquitin ligase regulates lysine ...